View More Recent Stories

Feb 22, 2022 08:00AM Sema4 and BioSymetrics Partner on Data-Driven Drug Discovery to Advance Precision Medicine
Feb 3, 2022 04:05PM Sema4 to Participate at Two Upcoming Investor Conferences in February
Feb 3, 2022 04:05PM Sema4 to Participate at Two Upcoming Investor Conferences in February
Feb 1, 2022 07:30AM Sema4 Announces Plans to Strengthen its Market Access Team to Drive Improved Commercial and Reimbursement Capabilities
Feb 1, 2022 07:30AM Sema4 Announces Plans to Strengthen its Market Access Team to Drive Improved Commercial and Reimbursement Capabilities
Jan 18, 2022 07:00AM Sema4 (SMFR) Acquires GeneDx from OPKO (OPK)
Jan 18, 2022 07:00AM Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform
Jan 18, 2022 07:00AM Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform
Jan 10, 2022 07:15AM Sema4 (SMFR) Reports Prelim Q4 Revenue
Jan 10, 2022 07:15AM Sema4 Announces Preliminary Revenue for the Fourth Quarter and Fiscal Year 2021
Jan 10, 2022 07:15AM Sema4 Announces Preliminary Revenue for the Fourth Quarter and Fiscal Year 2021
Jan 3, 2022 04:05PM Sema4 to Participate at the 40th Annual J.P. Morgan Healthcare Conference in January
Jan 3, 2022 04:05PM Sema4 to Participate at the 40th Annual J.P. Morgan Healthcare Conference in January
Nov 15, 2021 04:01PM Sema4 Reports Third Quarter 2021 Financial Results and Business Highlights
Nov 15, 2021 04:01PM Sema4 Reports Third Quarter 2021 Financial Results and Business Highlights
Nov 4, 2021 08:00AM Sema4 and Mount Sinai use Machine Learning to Improve Postpartum Hemorrhage Risk Prediction
Nov 4, 2021 08:00AM Sema4 and Mount Sinai use Machine Learning to Improve Postpartum Hemorrhage Risk Prediction
Nov 3, 2021 09:15AM Sema4 to Participate at Three Upcoming Investor Conferences in November
Nov 3, 2021 09:15AM Sema4 to Participate at Three Upcoming Investor Conferences in November
Oct 19, 2021 04:05PM Sema4 to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021
Oct 19, 2021 04:05PM Sema4 to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021
Sep 13, 2021 08:00AM Sema4 Appoints Computational Biology Expert Gustavo Stolovitzky as Chief Science Officer
Sep 9, 2021 08:00AM Sema4 Launches Sema4 Elements™, a Portfolio of Data Science-Driven Products and Services to Support Reproductive and Generational Health
Aug 30, 2021 04:05PM Sema4 to Participate at Two Upcoming Investor Conferences in September
Aug 30, 2021 04:05PM Sema4 to Participate at Two Upcoming Investor Conferences in September
Aug 16, 2021 04:05PM Sema4 Reports Second Quarter 2021 Financial Results and Business Highlights
Aug 16, 2021 04:05PM Sema4 Reports Second Quarter 2021 Financial Results and Business Highlights
Aug 11, 2021 08:00AM Avera Health and Sema4 Announce Collaboration to Advance Precision Oncology Care
Aug 2, 2021 09:00AM Sema4 to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021
Aug 2, 2021 09:00AM Sema4 to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021
Jul 28, 2021 04:05PM Sema4 to Participate at Two Upcoming Investor Conferences in August
Jul 28, 2021 04:05PM Sema4 to Participate at Two Upcoming Investor Conferences in August
Jul 22, 2021 09:15AM Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company
View More Recent Stories